MetLife Investment Management’s Mesa Laboratories MLAB Stock Holding History

MetLife Investment Management’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$308K	Buy	3,094 +206	+7%	+$20.7K	﹤0.01%	2196
2026 Q1	$255K	Hold	2,888	–	–	﹤0.01%	2096
2025 Q4	$227K	Hold	2,888	–	–	﹤0.01%	2210
2025 Q3	$194K	Hold	2,888	–	–	﹤0.01%	2336
2025 Q2	$272K	Hold	2,888	–	–	﹤0.01%	2015
2025 Q1	$343K	Sell	2,888 -68	-2%	-$9.27K	﹤0.01%	1911
2024 Q4	$390K	Hold	2,956	–	–	﹤0.01%	1932
2024 Q3	$384K	Hold	2,956	–	–	﹤0.01%	1927
2024 Q2	$256K	Buy	2,956 +288	+11%	+$30.2K	﹤0.01%	2092
2024 Q1	$293K	Hold	2,668	–	–	﹤0.01%	1970
2023 Q4	$280K	Hold	2,668	–	–	﹤0.01%	2047
2023 Q3	$280K	Hold	2,668	–	–	﹤0.01%	1999
2023 Q2	$343K	Hold	2,668	–	–	﹤0.01%	1938
2023 Q1	$466K	Hold	2,668	–	–	﹤0.01%	1687
2022 Q4	$443K	Hold	2,668	–	–	﹤0.01%	1714
2022 Q3	$376K	Hold	2,668	–	–	﹤0.01%	1842
2022 Q2	$544K	Hold	2,668	–	–	﹤0.01%	1590
2022 Q1	$680K	Buy	2,668 +938	+54%	+$255K	﹤0.01%	1587
2021 Q4	$568K	Hold	1,730	–	–	﹤0.01%	1444
2021 Q3	$523K	Buy	1,730 +170	+11%	+$48.3K	﹤0.01%	1493
2021 Q2	$423K	Hold	1,560	–	–	﹤0.01%	1671
2021 Q1	$380K	Sell	1,560 -460	-23%	-$127K	﹤0.01%	1679
2020 Q4	$579K	Hold	2,020	–	–	0.01%	1414
2020 Q3	$515K	Buy	2,020 +315	+18%	+$74.8K	0.01%	1354
2020 Q2	$370K	Hold	1,705	–	–	﹤0.01%	1540
2020 Q1	$385K	Hold	1,705	–	–	0.01%	1349
2019 Q4	$425K	Hold	1,705	–	–	﹤0.01%	1548
2019 Q3	$405K	Buy	1,705 +231	+16%	+$53.4K	﹤0.01%	1535
2019 Q2	$360K	Sell	1,474 -2,948	-67%	-$687K	﹤0.01%	1680
2019 Q1	$1.02M	Buy	4,422 +2,948	+200%	+$666K	﹤0.01%	1648
2018 Q4	$307K	Hold	1,474	–	–	﹤0.01%	1662
2018 Q3	$274K	Hold	1,474	–	–	﹤0.01%	1911
2018 Q2	$311K	Hold	1,474	–	–	﹤0.01%	1699
2018 Q1	$219K	Hold	1,474	–	–	﹤0.01%	1836
2017 Q4	$183K	Buy	+1,474	New	+$206K	﹤0.01%	1982

Other funds holding MLAB

LPP

Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

MetLife Investment Management's MLAB Position: Q2 2026 in Review

MetLife Investment Management increased its Mesa Laboratories (MLAB) stake by 7.1% in Q2 2026, buying an estimated $20.7K and bringing the position to 3,094 shares worth $308K. The position accounts for ﹤0.01% of the portfolio, ranked #2196.

MetLife Investment Management first reported a position in MLAB in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.02M in Q1 2019. 159 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

MetLife Investment Management held 3,094 shares of Mesa Laboratories worth $308K as of Q2 2026.
MetLife Investment Management bought 206 Mesa Laboratories shares in Q2 2026, an estimated $20.7K.
Mesa Laboratories made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2196 holding.
MetLife Investment Management first reported a position in Mesa Laboratories in Q4 2017 and has held it in 35 quarters since.
MetLife Investment Management's Mesa Laboratories position peaked at $1.02M in Q1 2019.
159 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.